|Articles|October 1, 2018
- BioPharm International-10-01-2018
- Volume 31
- Issue 10
BioPharm International, October 2018 Issue (PDF)
Click the title above to open the BioPharm International October 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
AAPS Traces the Path to ICH M10over 7 years ago
A Plastic Pipeline for Commercial Bioprocessing?over 7 years ago
Outsourcing Development: Small-Scale to Commercialover 7 years ago
The Link Between Data Integrity and Quality Cultureover 7 years ago
FDA Clarifies Worldwide Inspection PoliciesNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
4
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
5
